IL17A and rheumatoid arthritis: In contrast, a higher frequency of circulating IL-17A+IFNγ+ ex-Th17 cells predicts a good outcome from anti-TNF therapy highlighting these cells as a significant component of TNF-mediated inflammation in RA.